GAO Considers FDA Data Insufficient To Predict FY 2005 Review Performance
This article was originally published in The Gray Sheet
Executive Summary
The high volume of fiscal 2003 and 2004 submissions still pending at FDA precludes a thorough assessment of whether the agency will be able to meet FY 2005 device review performance goals under MDUFMA, according to the Government Accountability Office